Tempest Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 08/11/2025 | 269.77 K | $1.83 M | 100.00% | 7.09% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2025 | 25.72 K | $21.33 K | 0.00% | 0.68% |
| JPMORGAN CHASE & CO | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 08/11/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| DAVENPORT & CO LLC | 07/22/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/15/2025 | 0 | $0 | -100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 08/18/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 0 | $0 | -100.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 08/05/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 07/08/2025 | 0 | $0 | -100.00% | 0.00% |
| MAYTECH GLOBAL INVESTMENTS, LLC | 08/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLSTONE EVANS GROUP, LLC | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tempest Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Tempest Therapeutics, Inc.. The most heavily invested institutionals were:
Versant Venture Management, LLC: 269,772
ADVISOR GROUP HOLDINGS, INC.: 25,722
Parallel Advisors, LLC: 0
MayTech Global Investments, LLC: 0
Millstone Evans Group, LLC: 0
UBS Group AG: 0
7.77% of Tempest Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 845.74 K shares in the last 24 months. This purchase volume represents approximately $9.08 M in transactions.